Taurine Eye Drops May Prevent the Progression of Cataract

Phase 2Active Not RecruitingNCT06639711

University Of Anbar50 enrolled

Overview

The aim of the current intervention study is to determine the effectiveness of taurine containing eye drops (available under brand name VIZILOTON) to prevent the progression of grade I and II senile cataract. This study could answer: * Dose continuous use of taurine-containing eye drops could prevent further deterioration of vision in mild cases of cataract? * The acceptance/ compliance of participants to taurine-containing eye drops. * Could long-term use of taurine-containing eye drops cause adverse effect(s)? Participants will: * Take taurine-containing eye drops (VIZILOTON eye drops) 4 times a day for one year. * Visit eye clinic every 3 months for assessment and visual examination. * Keep notes for their symptoms and their adherence to treatment.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Cataract

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The presence of grade I or II senile cataract on one or two eyes. Exclusion Criteria: * clinical signs of glaucoma * history of amblyopia, eye surgery, argon or YAG laser eye treatment, or major eye trauma * history of iritis, retinal crystalline deposits, or optic nerve disease * visually significant fundus pathology

Taurine Eye Drops May Prevent the Progression of Cataract

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes